NCT01598896View on ClinicalTrials.gov

Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Cannabis DependenceMarijuana Dependence
Interventions
DRUG

Dronabinol

Dronabinol titrated to 5 mg three times daily

DRUG

Clonidine

Clonidine 0.1 mg twice daily

DRUG

Placebo

One placebo capsule by mouth twice daily

Trial Locations (1)

02478

McLean Hospital, Belmont

Sponsors
All Listed Sponsors
collaborator

Brain & Behavior Research Foundation

OTHER

lead

Mclean Hospital

OTHER